newsfilter
← Latest News
Business Wire·

Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase

Enrollment in the Expansion Phase Expected to Commence in September Deltacel Safety Confirmed at Day 30 in Trial's Fifth Patient; Efficacy Results on this Patient Expected in August Kiromic BioPharma, Inc.